Medinice S.A.

ICE

PLMDNCE00016

Advanced Medical Equipment & Technology

Market Closed - Warsaw S.E. Other stock markets 16:55:51 07/06/2024 BST			5-day change	1st Jan Change
7.81 ^PLN	-1.01%		+1.69%	-20.31%

05-28	Medinice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI
03-28	Medinice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	CI

Medinice S.A. announced that it has received PLN 7.400003 million in funding

August 31, 2019

Medinice S.A. announced a private placement of 986,667 shares at a price of PLN 7.5 per share for gross proceeds of PLN 7,400,002.5 on August 1, 2019.

Latest news about Medinice S.A.

Medinice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2024	05-28	CI
Medinice S.A. Reports Earnings Results for the Full Year Ended December 31, 2023	03-28	CI
Medinice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2023	11-09	CI
Medinice S.A. Reports Earnings Results for the Half Year Ended June 30, 2023	24/08/23	CI
Medinice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2023	11/05/23	CI
Medinice S.A. Reports Earnings Results for the Full Year Ended December 31, 2022	04/04/23	CI
Medinice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2022	09/11/22	CI
Medinice S.A. Reports Earnings Results for the Half Year Ended June 30, 2022	20/09/22	CI
Medinice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2022	11/05/22	CI
Medinice S.A. Reports Earnings Results for the Full Year Ended December 31, 2021	31/03/22	CI
An unknown buyer entered into an agreement to acquire Medi Ventures Sp. z o.o. from Medinice S.A..	07/12/21	CI
Medinice S.A. Reports Earnings Results for the Nine Months Ended September 30, 2021	23/11/21	CI
Medinice S.A. Reports Earnings Results for the Half Year Ended June 30, 2021	07/09/21	CI
Medinice S.A. announced that it has received PLN 24.89298 million in funding	06/06/21	CI
Medinice S.A. agreed to acquire 40% stake in JitMed for PLN 2.1 million.	30/05/21	CI
Medinice S.A. Reports Earnings Results for the First Quarter Ended March 31, 2021	20/05/21	CI
Medinice S.A. announced a financing transaction	18/05/21	CI
Medinice S.A. Reports Earnings Results for the Full Year Ended December 31, 2020	20/04/21	CI
Medinice S.A. announced that it has received PLN 7.400003 million in funding	31/07/19	CI

Medinice SA is a Poland-based company engaged in medical diagnostic and testing equipment business sector. The Company specializes in creating, developing and commercializing safe and minimally invasive solutions in the field of medicine, in particular cardiology and cardio surgery. Its portfolio comprises of projects, such as CathAIO, Cryoapplicator, Med-IConsole, Minimax, Pacepress and others. All of the Company's projects have a global potential. The Company cooperates with research centers in Poland and Europe. It strives to commercialize inventions brought by both co-founders of the Company and acquired projects through the sale of licenses worldwide in the production of medical devices.

Sector

Advanced Medical Equipment & Technology

More about the company

Income Statement Evolution

More financial data

Sector Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
MEDINICE S.A.	-20.31%	12.96M
SARTORIUS AG	-26.77%	16.85B
QUIDELORTHO CORPORATION	-43.46%	2.85B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+22.46%	1.96B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-12.32%	1.46B
BIOTAGE AB	+31.49%	1.34B
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-16.15%	940M
REVENIO GROUP OYJ	+1.33%	813M
CONTEC MEDICAL SYSTEMS CO.,LTD	-31.07%	767M
VAREX IMAGING CORPORATION	-25.95%	643M

Medical Diagnostic & Testing Equipment

Medinice S.A.

Equities

ICE

PLMDNCE00016

Advanced Medical Equipment & Technology

Medinice S.A. announced that it has received PLN 7.400003 million in funding

Latest news about Medinice S.A.

Chart Medinice S.A.

Company Profile

Income Statement Evolution

Sector Medical Diagnostic & Testing Equipment